Scholars@Duke

Should we avoid heparin to eliminate HIT?

Publication ,  Journal Article
Arepally, GM
Published in: Blood Adv
November 29, 2016
Published version (DOI) Link to item

Duke Scholars

Gowthami Morey Arepally
Author Gowthami Morey Arepally Medicine, Hematology
Altmetric Attention Stats
Dimensions Citation Stats

Published In

Blood Adv

DOI

10.1182/bloodadvances.2016000083

ISSN

2473-9529

Publication Date

November 29, 2016

Volume

1

Issue

1

Start / End Page

4

Location

United States

Related Subject Headings

  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Arepally, G. M. (2016). Should we avoid heparin to eliminate HIT? Blood Adv, 1(1), 4. https://doi.org/10.1182/bloodadvances.2016000083
Arepally, Gowthami Morey. “Should we avoid heparin to eliminate HIT?” Blood Adv 1, no. 1 (November 29, 2016): 4. https://doi.org/10.1182/bloodadvances.2016000083.
Arepally GM. Should we avoid heparin to eliminate HIT? Blood Adv. 2016 Nov 29;1(1):4.
Arepally, Gowthami Morey. “Should we avoid heparin to eliminate HIT?” Blood Adv, vol. 1, no. 1, Nov. 2016, p. 4. Pubmed, doi:10.1182/bloodadvances.2016000083.
Arepally GM. Should we avoid heparin to eliminate HIT? Blood Adv. 2016 Nov 29;1(1):4.

Published In

Blood Adv

DOI

10.1182/bloodadvances.2016000083

ISSN

2473-9529

Publication Date

November 29, 2016

Volume

1

Issue

1

Start / End Page

4

Location

United States

Related Subject Headings

  • 3201 Cardiovascular medicine and haematology